THE EFFECT OF FOLIC ACID AS ADDITIONAL THERAPY OF SPIRAMYCINE ON PHYSICAL DEFECT RISK OF FOETUS TO Toxoplasma gondii – INFECTED PREGNANT MICE (Mus musculus)

• Main Author: RAMADHANA YOGA PRABAWA, 061411131150
• Format: Theses and Dissertations NonPeerReviewed
• Language: Indonesian; Indonesian; Indonesian; Indonesian
• Published: 2019
• Subjects: Including veterinary genetics, ethology, anatomy, physiology, embryology, pathology
• Online Access: http://repository.unair.ac.id/88941/1/KKC%20KK%20KH%20156-19%20Pra%20e-Abstrak.pdf; http://repository.unair.ac.id/88941/2/KKC%20KK%20KH%20156-19%20Pra%20e-Daftar%20isi.pdf; http://repository.unair.ac.id/88941/3/KKC%20KK%20KH%20156-19%20Pra%20e-Daftar%20pustaka.pdf; http://repository.unair.ac.id/88941/4/KKC%20KK%20KH%20156-19%20Pra%20e.pdf; http://repository.unair.ac.id/88941/; http://lib.unair.ac.id
• Institution: Universitas Airlangga

This research aimed to investigate the effect of folic acid as additional therapy of spiramycine on physical defect risk of foetus to Toxoplasma gondii-infected pregnant mice (Mus musculus). Twenty pregnant female mice were divided into four groups as C -, C +, T1 and T2. C +, T1 and T2 were infecte...